Article
PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung.
Human pathology - 1 Dec 2016
Kim Sehui, Koh Jaemoon, Kim Moon-Young, Kwon Dohee, Go Heounjeong, Kim Young A, Jeon Yoon Kyung, Chung Doo Hyun
Abstract excerpt
PD-1/PD-L1-targeted immunotherapy has emerged as a promising therapeutic strategy for pulmonary adenocarcinoma (pADC). Epithelial-to-mesenchymal transition (EMT) is involved in the progression and immune evasion of cancers. Therefore, we investigated the association between PD-L1 expression and EMT phenotype in pADC. Immunohistochemistry for E-cadherin (epithelial marker), ZEB1, SNAIL, SLUG, vimentin (mesenchymal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
